The telehealth giant is entering the menopause market with a new line of treatment plans, meeting a long-overlooked need in women’s health as Millennials drive the shift toward digital care
Hims & Hers has already built one of the most visible names in telehealth. Now, it’s using that reach to take on perimenopause and menopause, with a line of treatment plans on the Hers side of the platform, which serves more than half a million subscribers and is on track to surpass $1 billion in annual revenue in 2026.
Starting Wednesday, eligible patients can work with a provider to access personalized treatment plans that may include prescription medication in pill, patch or cream form.
“This isn’t just about medication: it’s about building and growing a platform that women can trust to access the care they need,” said Hers chief medical officer Dr. Jessica Shepherd, who also serves as a Pvolve advisor. “Women have been navigating an outdated health care system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms.”
Such prescription medications may include estradiol, a hormone naturally produced in the body that helps alleviate symptoms such as hot flashes and night sweats and progesterone, which supports uterine health and improves sleep quality.
Once considered an overlooked corner of women’s health, it’s nearly impossible to ignore the reach of perimenopause and menopause or to underestimate their impact. Roughly 1.3 million U.S. women enter menopause each year, but the stakes go even deeper, as menopause symptoms cost the U.S. $1.8 billion in lost work time annually, with total medical and productivity costs reaching $26.6 billion, according to the Mayo Clinic.
Beyond the economic toll, there are personal ramifications that ripple across women’s lives. While the findings are based on Scandinavian labor data, a Stanford study found that women who sought care for menopause symptoms earned about 10% less over four years.
“I’ve been an OB-GYN for more than 20 years, and I know that transforming the health care experience for women starts with increasing access to providers who are trained specifically in caring for women at every life stage,” Dr. Shepherd said. “As one of the largest digital health platforms, we can help change the way women experience health care and thrive.”
An expanded range of treatment options is also in the works for next year, Hers confirms.
Earlier this month, the company published a new white paper detailing how rigorous standards, continuous monitoring and customer-centered design are shaping its approach to telehealth. In it, Hims & Hers reported that 94% of customers rated the quality of their care as good as or better than their prior in-person experience and demonstrated low rates of side effects across several categories, including GLP-1 medication, sexual and mental health and hair loss treatments.
The launch also lands as younger consumers continue to shape how health care is delivered, with a clear generational tilt toward digital care.
According to a June 2025 Harmony Healthcare IT survey, more than half of Millennials now prefer telehealth to traditional office visits, and 77% of Americans overall see remote care as the future of medicine. Notably, the oldest Millennials (now in their early forties) may already be entering perimenopause, marking the start of a new life stage for a generation that’s long shaped digital health trends.
Hims & Hers is expected to announce its third-quarter 2025 financial results on Nov. 3.
